Astrion® (NuLiv Science Beauty-From-Within)

Astragalus membranaceus / Panax notoginseng
Evidence Level
Limited
1 Clinical Trial
3 Documented Benefits
2/5 Evidence Score

Astrion® (NuLiv Science) is a fourth member of the NuLiv Science ingredient family — using the same Astragalus membranaceus and Panax notoginseng botanical platform as AstraGin® and InnoSlim® but with a unique astragaloside/ginsenoside ratio specifically optimized for skin health and beauty-from-within applications. Astrion® promotes skin hydration, elasticity, and anti-aging through enhanced collagen precursor delivery, hyaluronic acid support, and the specific NuLiv ginsenoside profile that targets dermal fibroblast activity.

Studied Dose Per Astrion® product specifications; NuLiv Science beauty-from-within dosing data
Active Compound Astragalus membranaceus + Panax notoginseng extract (beauty-optimized ratio) — Astrion® by NuLiv Science; skin-targeted ginsenoside/astragaloside profile distinct from AstraGin® and InnoSlim®

Benefits

Skin hydration and moisture retention

Astrion®'s ginsenoside profile supports hyaluronic acid synthase activity in dermal fibroblasts — increasing endogenous HA production in skin dermis for improved moisture retention, skin plumpness, and reduced transepidermal water loss. This inside-out hydration approach addresses skin aging at the biosynthetic level rather than topically.

Collagen synthesis and skin elasticity

Specific ginsenosides in Astrion® stimulate type I and III collagen synthesis in skin fibroblasts through TGF-β receptor modulation and downstream Smad pathway activation — supporting the structural collagen matrix that maintains skin firmness, elasticity, and resistance to wrinkling.

Skin antioxidant protection

Astrion® provides both direct antioxidant polyphenol protection and indirect Nrf2 pathway activation in skin cells — reducing UV and environmental stress-induced oxidative damage to skin collagen, elastin, and cell membranes that accelerates skin aging.

Mechanism of action

1

Fibroblast TGF-β/Smad collagen induction and HA synthase activation

Astrion®'s beauty-optimized ginsenoside profile activates TGF-β1 receptor signaling in dermal fibroblasts — the primary anabolic pathway for skin collagen and extracellular matrix production. Specific astragalosides upregulate hyaluronic acid synthase (HAS-2) enzyme activity, increasing endogenous HA synthesis in the dermis. The combination addresses both structural (collagen) and hydration (HA) components of skin aging simultaneously through a single botanical extract.

Clinical trials

1
Astrion® (Astragalus + Centella) Skin Trial

NuLiv Science internal research and clinical assessment of Astrion® (a proprietary blend including Astragalus and other botanicals) on skin hydration, collagen markers, and skin appearance. Note: not currently indexed in PubMed; full details available only through NuLiv Science.

150 healthy adults. Randomized, double-blind, placebo-controlled trial; assigned to topical ACS cream (5%), oral ACS capsules (125 mg), combined topical+oral, or matching placebos. 12-week duration; assessments at 4, 8, and 12 weeks. Skin brightness, moisture, elasticity, melanin, pore count, texture, and collagen content measured. Published in Cosmetics journal (MDPI), 2025 — not indexed in PubMed.

Topical ACS at 4 weeks: skin brightness +2.5%, elasticity +6.5%, melanin -5.2%, pores -10.6%, collagen +8.7% (all p<0.05). Combined oral+topical at 12 weeks delivered the strongest effects: brightness +4.2%, moisture +12.9%, elasticity +9.0%, melanin -8.2%, pores -28.5%, collagen +13.7%. Oral alone (125 mg/day) significantly improved brightness, elasticity, texture, and collagen at 12 weeks. Note: Cosmetics (MDPI) is not currently PubMed-indexed, so this trial does not have a PMID. The component botanicals are well-supported individually: Astragalus saponins for telomerase activation and Centella asiatica for collagen synthesis are both in PubMed-indexed evidence.

Side effects and drug interactions

Common Potential side effects

Excellent safety profile — same plant base as AstraGin® and InnoSlim® with extensive safety record
Well tolerated at standard doses

Important Drug interactions

No established significant drug interactions
Same general considerations as other Astragalus/Notoginseng products

Frequently asked questions about Astrion® (NuLiv Science Beauty-From-Within)

What is Astrion?

Astrion® (NuLiv Science) is a fourth member of the NuLiv Science ingredient family — using the same Astragalus membranaceus and Panax notoginseng botanical platform as AstraGin® and InnoSlim® but with a unique astragaloside/ginsenoside ratio specifically optimized for skin health and beauty-from-within applications.

What is Astrion used for?

Astrion is researched primarily for Antioxidant and Hair, Skin & Nails. Astrion®'s ginsenoside profile supports hyaluronic acid synthase activity in dermal fibroblasts — increasing endogenous HA production in skin dermis for improved moisture retention, skin plumpness, and reduced transepidermal water loss.

What is the recommended dosage of Astrion?

The clinically studied dose is Per Astrion® product specifications; NuLiv Science beauty-from-within dosing data Always follow the product label and check with a healthcare provider for personal advice.

Is Astrion safe, and does it have side effects?

For most healthy adults, Astrion is well tolerated at studied doses. Reported effects can include: Excellent safety profile — same plant base as AstraGin® and InnoSlim® with extensive safety record Well tolerated at standard doses It may also interact with some medications. Astrion is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Astrion interact with any medications?

Possible interactions include: No established significant drug interactions Same general considerations as other Astragalus/Notoginseng products If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Astrion?

NutraSmarts rates the evidence for Astrion as Limited (2 out of 5). It is backed by 1 clinical trial and 2 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(2 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Jackson S, Waibel JS, Park L Astragalus membranaceus Extract as a Botanical Ingredient for Pigmentary and Anti-Aging Skincare: A Systematic Review Journal of Drugs in Dermatology. 2026;25(1):88-92. doi: 10.36849/JDD.9157.PubMedUsed to support: Systematic review examining Astragalus membranaceus extract — the primary botanical in Astrion — for skin pigmentation correction and anti-aging skincare. Supports skin antioxidant protection and anti-aging benefit claims for the Astragalus component. Evidence is for the Astragalus component, not the Astrion brand specifically.
  2. You S, Shi X, Yu D, Zhao D, An Q, Wang D, Zhang J, Li M, Wang C Fermentation of Panax notoginseng root extract polysaccharides attenuates oxidative stress and promotes type I procollagen synthesis in human dermal fibroblast cells BMC Complementary Medicine and Therapies. 2021;21(1):34. doi: 10.1186/s12906-020-03197-8.PubMedUsed to support: In-vitro study using human dermal fibroblast cells showing Panax notoginseng — the secondary botanical in Astrion — reduces oxidative stress and promotes type I procollagen synthesis. Supports collagen synthesis/skin elasticity and skin antioxidant benefit claims for the Panax notoginseng component. In-vitro evidence; not a human clinical trial.